Circulating soluble neuropilin-1 in patients with early cervical cancer and cervical intraepithelial neoplasia can be used as a valuable diagnostic biomarker

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Yang, Shouhua ^a,b   Cheng, Henghui ^a   Huang, Zaiju ^a   Wang, Xiaoling ^a   Wan, Yinglu ^a   Cai, Jing ^a   Wang, Zehua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPILIN 1; SOLUBLE NEUROPILIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; PATHOLOGY; UTERINE CERVIX TUMOR;

ADULT; AGED; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; NEUROPILIN-1; UTERINE CERVICAL NEOPLASMS;

EID: 84926500685     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/506428     Document Type: Article

References (27)

1. J. Ferlay, I. Soerjomataram, R. Dikshit et al., "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012", International Journal of Cancer, Vol. 136, no. 5, pp. E359-E386, 2015.
2. A. Stafl and R. F. Mattingly, "Angiogenesis of cervical neoplasia", American Journal of Obstetrics & Gynecology, Vol. 121, no. 6, pp. 845-852, 1975.
3. G. L. Bremer, A. T. M. G. Tiebosch, H. W. H. M. Van der Putten, H. J. A. Schouten, J. De Haan, and J.-W. Arends, "Tumor angiogenesis: an independent prognostic parameter in cervical cancer", American Journal of Obstetrics & Gynecology, Vol. 174, no. 1, pp. 126-131, 1996.
4. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak, "Vascular endothelial growth factor (VEGF) and its receptors", The FASEB Journal, Vol. 13, no. 1, pp. 9-22, 1999.
5. A. Bagri, M. Tessier-Lavigne, and R. J. Watts, "Neuropilins in tumor biology", Clinical Cancer Research, Vol. 15, no. 6, pp. 1860-1864, 2009.
6. K. A. Uniewicz, M. J. Cross, and D. G. Fernig, "Exogenous recombinant dimeric neuropilin-1 is suficient to drive angio-genesis", The Journal of Biological Chemistry, Vol. 286, no. 1, pp. 12-23, 2011.
7. P. Carmeliet and R. K. Jain, "Angiogenesis in cancer and other diseases", Nature, Vol. 407, no. 6801, pp. 249-257, 2000.
8. N. Ferrara, H.-P. Gerber, and J. LeCouter, "The biology of VEGF and its receptors", Nature Medicine, Vol. 9, no. 6, pp. 669-676, 2003.
9. C. Pellet-Many, P. Frankel, H. Jia, and I. Zachary, "Neuropilins: structure, function and role in disease", Biochemical Journal, Vol. 411, no. 2, pp. 211-226, 2008.
10. M. Murga, O. Fernandez-Capetillo, and G. Tosato, "Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2", Blood, Vol. 105, no. 5, pp. 1992-1999, 2005.
11. C. Raimondi, A. Fantin, A. Lampropoulou, L. Denti, A. Chikh, and C. Ruhrberg, "Imatinib inhibits VEGF-independent angio-genesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells", Journal of Experimental Medicine, Vol. 211, no. 6, pp. 1167-1183, 2014.
12. H. Ding, X. Wu, L. Roncari et al., "Expression and regulation of neuropilin-1 in human astrocytomas", International Journal of Cancer, Vol. 88, no. 4, pp. 584-592, 2000.
13. Q. Ben, J. Zheng, J. Fei et al., "High neuropilin 1 expression was associated with angiogenesis and poor overall survival in resected pancreatic ductal adenocarcinoma", Pancreas, Vol. 43, pp. 744-749, 2014.
14. W. Cheng, D. Fu, Z. F. Wei et al., "NRP-1 expression in bladder cancer and its implications for tumor progression", Tumour Biology, Vol. 35, no. 6, pp. 6089-6094, 2014.
15. J. Xu and J. Xia, "NRP-1 silencing suppresses hepatocellular carcinoma cell growth in vitro and in vivo", Experimental and Therapeutic Medicine, Vol. 5, no. 1, pp. 150-154, 2013.
16. Y. Xu, P. Li, X. Zhang, J. Wang, D. Gu, and Y. Wang, "Prognostic implication of neuropilin-1 upregulation in human nasopha-ryngeal carcinoma", Diagnostic Pathology, Vol. 8, no. 1, article no. 155, 2013.
17. A. M. Jubb, L. A. Strickland, S. D. Liu, J. Mak, M. Schmidt, and H. Koeppen, "Neuropilin-1 expression in cancer and development", Journal of Pathology, Vol. 226, no. 1, pp. 50-60, 2012.
18. H. Zhu, H. Cai, M. Tang, and J. Tang, "Neuropilin-1 is overex-pressed in osteosarcoma and contributes to tumor progression and poor prognosis", Clinical and Translational Oncology, Vol. 16, no. 8, pp. 732-738, 2014.
19. M. Kreuter, K. Woelke, R. Bieker et al., "Correlation of neuropil-in-1 overexpression to survival in acute myeloid leukemia", Leukemia, Vol. 20, no. 11, pp. 1950-1954, 2006.
20. A. Piechnik, A. Dmoszynska, M. Omiotek et al., "The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients", International Journal of Cancer, Vol. 133, no. 6, pp. 1489-1496, 2013.
21. J. Zhao, L. Gu, C. Li, W. Ma, and Z. Ni, "Investigation of a novel biomarker, neuropilin-1, and its application for poor prognosis in acute myeloid leukemia patients", Tumor Biology, Vol. 35, no. 7, pp. 6919-6924, 2014.
22. Y. Lu, H. Xiang, P. Liu et al., "Identification of circulating neuropilin-1 and dose-dependent elevation following anti-neuropilin-1 antibody administration", mAbs, Vol. 1, no. 4, pp. 364-369, 2009.
23. T. Ochiumi, Y. Kitadai, S. Tanaka et al., "Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer", International Journal of Oncology, Vol. 29, pp. 105-116, 2006.
24. S. A. I. Adham, I. Al Harrasi, I. Al Haddabi et al., "Immunohistological insight into the correlation between neuropilin-1 and epithelial-mesenchymal transition markers in epithelial ovarian cancer", Journal of Histochemistry & Cytochemistry, Vol. 62, no. 9, pp. 619-631, 2014.
25. G. M. Delgoffe, S.-R. Woo, M. E. Turnis et al., "Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis", Nature, Vol. 501, no. 7466, pp. 252-256, 2013.
26. B. Chaudhary and E. Elkord, "Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases", Expert Opinion on Therapeutic Targets, Vol. 19, no. 2, pp. 147-161, 2015.
27. A. Casazza, D. Laoui, M. Wenes et al., "Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity", Cancer Cell, Vol. 24, no. 6, pp. 695-709, 2013.